article · Acta Crystallographica Section E Crystallographic Communications
Lopinavir is a potent protease inhibitor that is used as a first-line pharmaceutical drug for the treatment of HIV. The multi-component solvated Lopinavir crystal, systematic name (2<i>S</i>)-<i>N</i>-[(2<i>S</i>,4<i>S</i>,5<i>S</i>)-5-[2-(2,6-di-methyl-phen-oxy)acetamido]-4-hy-droxy-1,6-di-phenyl-hexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide-ethane-1,2-diol-water (8/3/7) 8C<sub>37</sub>H<sub>48</sub>N<sub>4</sub>O<sub>5</sub>·3C<sub>2</sub>H<sub>6</sub>O<sub>2</sub>·7H<sub>2</sub>O, was prepared using evaporative methods. The crystalline material obtained from this experimental synthesis was characterized and elucidated by single-crystal X-ray diffraction (SC-XRD). The crystal structure is unusual in that the unit cell contains 18 mol-ecules. The stoichiometric ratio of this crystal is eight Lopinavir mol-ecules [8(C<sub>37</sub>H<sub>48</sub>N<sub>4</sub>O<sub>5</sub>)], three ethane-1,2-diol mol-ecules [3(C<sub>2</sub>H<sub>6</sub>O<sub>2</sub>)] and seven water mol-ecules [7(H<sub>2</sub>O)]. The crystal packing features both bi- and trifurcated hydrogen bonds between atoms.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1107/s2056989024004158
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
